Arylamine N-Acetyltransferase Is Required for Synthesis of Mycolic Acids and Complex Lipids in Mycobacterium bovis BCG and Represents a Novel Drug Target
Open Access
- 26 April 2004
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 199 (9), 1191-1199
- https://doi.org/10.1084/jem.20031956
Abstract
Mycolic acids represent a major component of the unique cell wall of mycobacteria. Mycolic acid biosynthesis is inhibited by isoniazid, a key frontline antitubercular drug that is inactivated by mycobacterial and human arylamine N-acetyltransferase (NAT). We show that an in-frame deletion of Mycobacterium bovis BCG nat results in delayed entry into log phase, altered morphology, altered cell wall lipid composition, and increased intracellular killing by macrophages. In particular, deletion of nat perturbs biosynthesis of mycolic acids and their derivatives and increases susceptibility of M. bovis BCG to antibiotics that permeate the cell wall. Phenotypic traits are fully complemented by introduction of Mycobacterium tuberculosis nat. We infer from our findings that NAT is critical to normal mycolic acid synthesis and hence other derivative cell wall components and represents a novel target for antituberculosis therapy. In addition, this is the first report of an endogenous role for NAT in mycobacteria.This publication has 46 references indexed in Scilit:
- Crystal Structure of Mycobacterium tuberculosis MenB, a Key Enzyme in Vitamin K2 BiosynthesisJournal of Biological Chemistry, 2003
- Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in MycobacteriaOnline Journal of Public Health Informatics, 2003
- Apoptosis Modulation by Mycolic Acid, Tuberculostearic Acid and Trehalose 6,6′-DimycolateJournal of Infection, 2002
- The Structure of Arylamine N-acetyltransferase from Mycobacterium smegmatis—An Enzyme which Inactivates the Anti-tubercular Drug, IsoniazidJournal of Molecular Biology, 2002
- Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticityMolecular Microbiology, 2000
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Chemical and ultrastructural investigations ofMycobacterium bovisBCG: implications for the molecular structure of the mycobacterial cell envelopeFEMS Immunology & Medical Microbiology, 1996
- TO‐PRO‐3 iodide: A novel HeNe laser‐excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometryCytometry, 1994
- Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosisJournal of General Microbiology, 1970
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960